chronic hepatitis B
Conditions
Interventions
???vs???? ???vs???? Recurrence group vs non recurrence group:Nil
Sponsors
Beijing Youan Hospital, Capital Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: (1) Ages 18 to 60, regardless of gender; (2) All patients with chronic HBV infection were stopped after HBsAg clearance obtained by interferon or combined WITH NA treatment; (3) The baseline clinical types of patients with chronic HBV infection include: HBEag-positive CHB (EP-CHB), Hbeag-negative CHB (EN-CHB), inactive HBsAg carrier (IHC), and DRUG-resistance CHB (DR-CHB). (4) Add informed consent to the cohort follow-up.
Exclusion criteria
Exclusion criteria: (1) CO-infection of HIV, HAV, HCV and HDV, decompensated cirrhosis, liver cancer, autoimmune liver disease, etc.; (2) All relapsed patients were asked about their medical history in detail, and immunosuppressive drugs, cytotoxic drugs, hormones and other drug histories were excluded; (3) Exclude recent blood transfusion, unclean injection and tattoo history; (4) Those who signed the informed consent at the time of registration but could not cooperate during the follow-up were excluded; Those who do not understand the content of the informed consent and cannot sign it; Other things the researchers think.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HBcrAg; | — |
Countries
China
Contacts
Public ContactRen Shan
Beijing Youan Hospital, Capital Medical University
Outcome results
None listed